Abcam 2023 Investor Presentation | Life Science Reagents Leader

Abcam is a leader in life science research reagents with £362M in 2022 revenues and adjusted gross margins exceeding 75%. The company generates 100% recurring revenues with 67% derived from in-house products and maintains complete exposure to the life sciences market. This presentation outlines Abcam's resilient growth strategy amid challenging market conditions.